[Problems of glycoside therapy in kidney insufficiency and uremia].
D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006027:Glycosides / Q000097:blood / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood*; D008657:Metabolic Clearance Rate; D011442:Proscillaridin / Q000627:therapeutic use; D013328:Strophanthins / Q000627:therapeutic use; D014511:Uremia / Q000097:blood*
D006027:Glycosides; D013328:Strophanthins; D004077:Digoxin; D004074:Digitoxin; D011442:Proscillaridin
Probleme der Glykosidtherapie bei Niereninsuffizienz und Urämie.